A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1

Background: Autism Spectrum Disorder (ASD or autism) is characterized by difficulties in social communication and interaction, which negatively impact on individuals and their families' quality of life. Currently no pharmacological interventions have been shown to be effective for improving soc...

Descripción completa

Detalles Bibliográficos
Autores principales: Parellada, Mara, San José Cáceres, Antonia, Palmer, Melanie, Delorme, Richard, Jones, Emily J. H., Parr, Jeremy R., Anagnostou, Evdokia, Murphy, Declan G. M., Loth, Eva, Wang, Paul P., Charman, Tony, Strydom, Andre, Arango, Celso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421761/
https://www.ncbi.nlm.nih.gov/pubmed/34504446
http://dx.doi.org/10.3389/fpsyt.2021.701729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421761/
https://www.ncbi.nlm.nih.gov/pubmed/34504446
http://dx.doi.org/10.3389/fpsyt.2021.701729

Ejemplares similares